GeneSys Bio
PrivateLast Round
Grant
Jun 1, 2024
Total Funding Raised
$260,700
Momentum
Top 10%
of companies Caplight tracks
Company Overview
GeneSys Bio is a biotechnology company that develops portable, AI-driven molecular diagnostic platforms for the rapid detection of pathogens and antibiotic resistance.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical AI, Environmental Monitoring
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneSys Bio Comparables
Compare GeneSys Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innotive Diagnostics | 85% | |
| Llusern Scientific | 84% | |
| Detechgene | 83% |
GeneSys Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2024 | ||||
| Grant | May 1, 2024 | ||||
| Accelerator | Jul 1, 2023 |
Key People
Founding team and executive leadership
GeneSys Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AC75 Startup Accelerator | Accelerator |
| CDP Venture Capital SGR | Accelerator |
| Lazio Innova | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 202% MoM, reaching 2.4K.
- Jun 19, 2026
Monthly visitors increased 57% MoM.
GeneSys Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GeneSys Bio's valuation, stock price, and market status.
Is GeneSys Bio a public or private company?
GeneSys Bio is a private company.
What is the current stock price of GeneSys Bio?
GeneSys Bio is a private company with no public stock price. Caplight tracks GeneSys Bio's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is GeneSys Bio worth (valuation)?
Valuation information for GeneSys Bio is not publicly available.
Can I buy GeneSys Bio stock?
GeneSys Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GeneSys Bio's last funding round?
GeneSys Bio's most recent funding round was Grant on June 1, 2024.
Who are the main investors in GeneSys Bio?
Key investors in GeneSys Bio include AC75 Startup Accelerator, CDP Venture Capital SGR, Lazio Innova.
Will GeneSys Bio IPO soon?
No public IPO plans have been announced for GeneSys Bio.
How can I track GeneSys Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GeneSys Bio's secondary market activity and sign up for updates.